ChartMill assigns a Buy % Consensus number of 82% to LCTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-03-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | Maxim Group | Maintains | Buy -> Buy |
| 2025-01-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-18 | D. Boral Capital | Initiate | Buy |
| 2024-08-20 | Craig-Hallum | Initiate | Buy |
| 2024-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-25 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-02 | Baird | Initiate | Outperform |
The consensus rating for LINEAGE CELL THERAPEUTICS IN (LCTX) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.